Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[LutherTiggs]

Yes, believe Nilvadipine is in Phase 3 in Europe...and fairly long term study that as I recall extends out through 2016. A consortium of a number of interests are involved in the study outside of Archer, who is but a participant...and I am sure, Dr. Mullan has been a signficant contributor. People have been guessing for a long time what may become of RCPI relative to Archer (aka combined?)...but I have not heard anything from RCPI (including Dr. Mullan) referencing connections there. Hard to imagine Dr. Mullan not seeing a connection with Archer/Alz research and antabine though given how long he's been involved with both.